Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Clasificación en acciones
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Precio por acción
$8.03
Capitalización bursátil
$6.31B
Cambio (1 día)
1.07%
Cambio (1 año)
-8.04%
País
CN
Comercio Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Categoría
Healthcare
Ratio P/S de Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Ratio P/S al October 2026 TTM: 8.75
Según los informes financieros más recientes y el precio de las acciones de Shenzhen New Industries Biomedical Engineering Co., Ltd., el ratio P/S actual (TTM) es 8.75. Al final de 2024, el ratio P/S era 12.27.
Historial del ratio P/S de Shenzhen New Industries Biomedical Engineering Co., Ltd. desde 2012 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2026 (TTM) | 8.75 | -9.40% |
| 2025 | 9.66 | -21.32% |
| 2024 | 12.27 | -21.47% |
| 2023 | 15.63 | 20.88% |
| 2022 | 12.93 | -4.70% |
| 2021 | 13.57 | -45.22% |
| 2020 | 24.77 | 123.84% |
| 2019 | 11.06 | -8.57% |
| 2018 | 12.10 | -17.57% |
| 2017 | 14.68 | -19.11% |
| 2016 | 18.15 | -19.42% |
| 2015 | 22.52 | -24.61% |
| 2014 | 29.87 | -30.65% |
| 2013 | 43.08 | -31.74% |
| 2012 | 63.12 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 3.74 | -57.32% |
US
|
|
| 3.23 | -63.08% |
IE
|
|
| 4.58 | -47.71% |
US
|
|
| 3.07 | -64.89% |
US
|
|
| 2.02 | -76.95% |
DE
|
